| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 2.00e-08 | 4 | 239 | 4 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 2.00e-08 | 4 | 239 | 4 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 2.00e-08 | 4 | 239 | 4 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 9.91e-08 | 5 | 239 | 4 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 9.91e-08 | 5 | 239 | 4 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 9.91e-08 | 5 | 239 | 4 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 9.91e-08 | 5 | 239 | 4 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 9.91e-08 | 5 | 239 | 4 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 9.91e-08 | 5 | 239 | 4 | GO:0047086 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 9.91e-08 | 5 | 239 | 4 | GO:0047787 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 2.95e-07 | 6 | 239 | 4 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 6.81e-07 | 7 | 239 | 4 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 1.35e-06 | 8 | 239 | 4 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 1.35e-06 | 8 | 239 | 4 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 1.35e-06 | 8 | 239 | 4 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 2.41e-06 | 9 | 239 | 4 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 2.41e-06 | 9 | 239 | 4 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 3.97e-06 | 10 | 239 | 4 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 3.97e-06 | 10 | 239 | 4 | GO:0032052 | |
| GeneOntologyMolecularFunction | NADPH binding | 1.26e-05 | 26 | 239 | 5 | GO:0070402 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 1.53e-05 | 27 | 239 | 5 | GO:0008139 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 1.82e-05 | 14 | 239 | 4 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 1.82e-05 | 14 | 239 | 4 | GO:0001758 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 3.64e-05 | 32 | 239 | 5 | GO:0004033 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 8.34e-05 | 20 | 239 | 4 | GO:0004303 | |
| GeneOntologyMolecularFunction | nuclear import signal receptor activity | 8.34e-05 | 20 | 239 | 4 | GO:0061608 | |
| GeneOntologyMolecularFunction | macrophage colony-stimulating factor receptor activity | 1.43e-04 | 2 | 239 | 2 | GO:0005011 | |
| GeneOntologyMolecularFunction | sulfonylurea receptor activity | 1.43e-04 | 2 | 239 | 2 | GO:0008281 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 1.76e-04 | 24 | 239 | 4 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 2.43e-04 | 26 | 239 | 4 | GO:0004022 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 2.60e-04 | 11 | 239 | 3 | GO:0030283 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 2.65e-04 | 48 | 239 | 5 | GO:0016620 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 2.83e-04 | 27 | 239 | 4 | GO:0008106 | |
| GeneOntologyMolecularFunction | signal sequence binding | 3.53e-04 | 51 | 239 | 5 | GO:0005048 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 4.29e-04 | 30 | 239 | 4 | GO:0018455 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 5.47e-04 | 56 | 239 | 5 | GO:0016903 | |
| GeneOntologyMolecularFunction | nucleocytoplasmic carrier activity | 5.53e-04 | 32 | 239 | 4 | GO:0140142 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 6.23e-04 | 33 | 239 | 4 | GO:0033764 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 7.00e-04 | 34 | 239 | 4 | GO:0016628 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 7.53e-04 | 60 | 239 | 5 | GO:0016655 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ALKBH4 DIS3L2 SRCAP LCMT2 DQX1 PTRH1 XRN1 ASCC3 DSCC1 SLFN12 CHD1L HELQ METTL25B SLFN13 N4BP2 MARF1 TREX2 SLFN11 | 8.01e-04 | 645 | 239 | 18 | GO:0140640 |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 8.43e-04 | 4 | 239 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | NADP binding | 8.75e-04 | 62 | 239 | 5 | GO:0050661 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 1.18e-03 | 39 | 239 | 4 | GO:0016229 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 1.30e-03 | 40 | 239 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.72e-03 | 184 | 239 | 8 | GO:0022832 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | DIS3L2 INPP1 HNF4A PTRH1 XRN1 PNPLA2 PPM1D SLFN12 CASR IDS PPP2R1A ARSD SLFN13 NT5DC2 N4BP2 MARF1 TREX2 SLFN11 ABHD12 PHLPP2 | 1.76e-03 | 807 | 239 | 20 | GO:0016788 |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.82e-03 | 107 | 239 | 6 | GO:0033293 | |
| GeneOntologyMolecularFunction | ATP-activated inward rectifier potassium channel activity | 2.07e-03 | 6 | 239 | 2 | GO:0015272 | |
| GeneOntologyMolecularFunction | helicase activity | 2.98e-03 | 158 | 239 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | NUBP1 SRCAP DNAH14 DQX1 ABCC8 ASCC3 DSCC1 ABCC1 HSPA4L RNF213 ABCC9 CHD1L HELQ DNAH1 SLFN13 SLFN11 | 3.07e-03 | 614 | 239 | 16 | GO:0140657 |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 1.64e-08 | 4 | 235 | 4 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 1.64e-08 | 4 | 235 | 4 | GO:0006709 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 1.64e-08 | 4 | 235 | 4 | GO:0008208 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 1.64e-08 | 4 | 235 | 4 | GO:0071395 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 8.14e-08 | 5 | 235 | 4 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 8.14e-08 | 5 | 235 | 4 | GO:0120256 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 8.14e-08 | 5 | 235 | 4 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 8.14e-08 | 5 | 235 | 4 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 8.14e-08 | 5 | 235 | 4 | GO:0045827 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 8.14e-08 | 5 | 235 | 4 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 2.42e-07 | 6 | 235 | 4 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 2.42e-07 | 6 | 235 | 4 | GO:0016095 | |
| GeneOntologyBiologicalProcess | cell cycle process | ALKBH4 DPF1 DIS3L2 PIDD1 NUBP1 POGZ CUL7 MDM2 BIRC6 USP19 PNMA5 PTTG3P RPTOR CRLF3 FBXO7 FES DSCC1 KPNB1 CACNB4 SEPTIN5 PPM1D GTSE1 SLFN12 MEI1 SPAG5 TUBGCP6 PPP2R1A LIMK2 PBRM1 CSF1R TK1 MARF1 SMARCB1 CCAR2 SLFN11 PRKDC CKAP2 DOT1L ANKFN1 | 3.84e-07 | 1441 | 235 | 39 | GO:0022402 |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 5.60e-07 | 7 | 235 | 4 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 5.60e-07 | 7 | 235 | 4 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 5.60e-07 | 7 | 235 | 4 | GO:1900052 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | DPF1 PIDD1 MDM2 RPTOR CRLF3 FBXO7 CACNB4 GTSE1 SLFN12 PBRM1 CSF1R SMARCB1 SLFN11 PRKDC | 9.54e-07 | 246 | 235 | 14 | GO:1902806 |
| GeneOntologyBiologicalProcess | regulation of G1/S transition of mitotic cell cycle | DPF1 PIDD1 MDM2 RPTOR CRLF3 FBXO7 CACNB4 GTSE1 SLFN12 PBRM1 SMARCB1 SLFN11 PRKDC | 1.08e-06 | 213 | 235 | 13 | GO:2000045 |
| GeneOntologyBiologicalProcess | negative regulation of G1/S transition of mitotic cell cycle | 1.81e-06 | 98 | 235 | 9 | GO:2000134 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 1.98e-06 | 9 | 235 | 4 | GO:0044597 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 3.27e-06 | 10 | 235 | 4 | GO:0019747 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 3.27e-06 | 10 | 235 | 4 | GO:0044598 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 3.27e-06 | 10 | 235 | 4 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 3.27e-06 | 10 | 235 | 4 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 3.27e-06 | 10 | 235 | 4 | GO:0030647 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 4.14e-06 | 22 | 235 | 5 | GO:1902644 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle G1/S phase transition | 4.40e-06 | 109 | 235 | 9 | GO:1902807 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 5.09e-06 | 11 | 235 | 4 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 5.09e-06 | 11 | 235 | 4 | GO:0016115 | |
| GeneOntologyBiologicalProcess | cell cycle G1/S phase transition | DPF1 PIDD1 MDM2 RPTOR CRLF3 FBXO7 CACNB4 GTSE1 SLFN12 PBRM1 CSF1R SMARCB1 SLFN11 PRKDC | 1.20e-05 | 306 | 235 | 14 | GO:0044843 |
| GeneOntologyBiologicalProcess | DNA damage response | DPF1 SUPT20HL1 PIDD1 SUPT20HL2 POGZ MDM2 PTTG3P HROB RPTOR AP5Z1 ASCC3 BRAT1 SUPT20H PPM1D GTSE1 CHD1L HELQ FAAP100 PBRM1 MARF1 SMARCB1 CCAR2 TREX2 SLFN11 PRKDC HDAC10 DOT1L | 1.43e-05 | 959 | 235 | 27 | GO:0006974 |
| GeneOntologyBiologicalProcess | G1/S transition of mitotic cell cycle | DPF1 PIDD1 MDM2 RPTOR CRLF3 FBXO7 CACNB4 GTSE1 SLFN12 PBRM1 SMARCB1 SLFN11 PRKDC | 1.49e-05 | 271 | 235 | 13 | GO:0000082 |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 1.50e-05 | 14 | 235 | 4 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 1.50e-05 | 14 | 235 | 4 | GO:0008300 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 2.03e-05 | 15 | 235 | 4 | GO:0016102 | |
| GeneOntologyBiologicalProcess | rRNA catabolic process | 2.03e-05 | 15 | 235 | 4 | GO:0016075 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 2.68e-05 | 16 | 235 | 4 | GO:0061370 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 2.68e-05 | 16 | 235 | 4 | GO:0032351 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 4.43e-05 | 18 | 235 | 4 | GO:0030656 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 4.52e-05 | 35 | 235 | 5 | GO:0120255 | |
| GeneOntologyBiologicalProcess | cellular response to nutrient levels | LRRK2 MDM2 MAP3K5 RPTOR ABCC8 FES SIK2 GCN1 COMT PPM1D CASR PRKAG3 | 5.00e-05 | 262 | 235 | 12 | GO:0031669 |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 8.19e-05 | 91 | 235 | 7 | GO:0051055 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 8.44e-05 | 21 | 235 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 8.44e-05 | 21 | 235 | 4 | GO:0016114 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 8.44e-05 | 21 | 235 | 4 | GO:0048385 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 8.44e-05 | 21 | 235 | 4 | GO:0042182 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 8.44e-05 | 21 | 235 | 4 | GO:0042574 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | DPF1 DIS3L2 PIDD1 CUL7 MDM2 HNF4A RPTOR CRLF3 FBXO7 NLE1 KPNB1 CACNB4 TTC28 PPM1D GTSE1 SLFN12 SPAG5 TUBGCP6 PPP2R1A PBRM1 TK1 SMARCB1 SLFN11 PRKDC CKAP2 ANKFN1 | 9.86e-05 | 1014 | 235 | 26 | GO:0000278 |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 1.02e-04 | 22 | 235 | 4 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 1.02e-04 | 22 | 235 | 4 | GO:0042448 | |
| GeneOntologyBiologicalProcess | parturition | 1.02e-04 | 22 | 235 | 4 | GO:0007567 | |
| GeneOntologyBiologicalProcess | glycosyl compound metabolic process | 1.15e-04 | 96 | 235 | 7 | GO:1901657 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 1.23e-04 | 23 | 235 | 4 | GO:0071379 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 1.23e-04 | 23 | 235 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | SUPT20HL1 SUPT20HL2 AKR1C4 YTHDC1 AKR1C1 AKR1C2 SUPT20H NUP98 PRX AKR1C3 | 1.37e-04 | 207 | 235 | 10 | GO:0043484 |
| GeneOntologyBiologicalProcess | regulation of small molecule metabolic process | SUPT20HL1 SUPT20HL2 AKR1C4 HNF4A AKR1C1 AKR1C2 RPTOR SIK2 SUPT20H COMT SLC4A1 PRKAG3 SCAP MALRD1 AKR1C3 | 1.46e-04 | 434 | 235 | 15 | GO:0062012 |
| GeneOntologyBiologicalProcess | C21-steroid hormone metabolic process | 1.55e-04 | 45 | 235 | 5 | GO:0008207 | |
| GeneOntologyBiologicalProcess | DNA repair | DPF1 SUPT20HL1 SUPT20HL2 POGZ PTTG3P HROB AP5Z1 ASCC3 SUPT20H CHD1L HELQ FAAP100 PBRM1 MARF1 SMARCB1 TREX2 PRKDC HDAC10 DOT1L | 1.69e-04 | 648 | 235 | 19 | GO:0006281 |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 2.02e-04 | 26 | 235 | 4 | GO:0010566 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | DPF1 SUPT20HL1 SUPT20HL2 POGZ PTTG3P HROB AP5Z1 CIZ1 XRN1 ASCC3 DSCC1 SUPT20H SMG5 CHD1L HELQ FAAP100 PBRM1 TK1 N4BP2 MARF1 SMARCB1 TREX2 SLFN11 PRKDC HDAC10 DOT1L | 2.70e-04 | 1081 | 235 | 26 | GO:0006259 |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 2.71e-04 | 28 | 235 | 4 | GO:0048025 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | DPF1 PIDD1 NUBP1 CUL7 MDM2 BIRC6 USP19 RPTOR CRLF3 FBXO7 CACNB4 GTSE1 SLFN12 SPAG5 PPP2R1A PBRM1 CSF1R SMARCB1 CCAR2 SLFN11 PRKDC DOT1L | 2.80e-04 | 845 | 235 | 22 | GO:0010564 |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | DPF1 PIDD1 MDM2 RPTOR CRLF3 FBXO7 CACNB4 GTSE1 SLFN12 PBRM1 CSF1R SMARCB1 CCAR2 SLFN11 PRKDC DOT1L | 3.01e-04 | 516 | 235 | 16 | GO:1901987 |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 3.12e-04 | 29 | 235 | 4 | GO:0016093 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 3.12e-04 | 29 | 235 | 4 | GO:0050686 | |
| GeneOntologyBiologicalProcess | negative regulation of small molecule metabolic process | 3.16e-04 | 149 | 235 | 8 | GO:0062014 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | DPF1 DIS3L2 PIDD1 CUL7 MDM2 RPTOR CRLF3 FBXO7 KPNB1 CACNB4 PPM1D GTSE1 SLFN12 SPAG5 PPP2R1A PBRM1 TK1 SMARCB1 SLFN11 PRKDC CKAP2 ANKFN1 | 3.24e-04 | 854 | 235 | 22 | GO:1903047 |
| GeneOntologyBiologicalProcess | chromosome organization | DPF1 DIS3L2 POGZ PTTG3P XRN1 ASCC3 DSCC1 KPNB1 NUP98 SMG5 CHD1L MEI1 HELQ SPAG5 PPP2R1A PBRM1 SMARCB1 PRKDC DOT1L | 3.46e-04 | 686 | 235 | 19 | GO:0051276 |
| GeneOntologyBiologicalProcess | regulation of platelet formation | 3.85e-04 | 3 | 235 | 2 | GO:1905219 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle | PIDD1 MDM2 HNF4A CRLF3 FBXO7 NLE1 CACNB4 GTSE1 SLFN12 SLFN11 PRKDC | 4.12e-04 | 282 | 235 | 11 | GO:0045930 |
| GeneOntologyBiologicalProcess | prostaglandin metabolic process | 4.38e-04 | 56 | 235 | 5 | GO:0006693 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 4.60e-04 | 32 | 235 | 4 | GO:2000353 | |
| GeneOntologyBiologicalProcess | positive regulation of gluconeogenesis | 4.60e-04 | 32 | 235 | 4 | GO:0045722 | |
| GeneOntologyBiologicalProcess | prostanoid metabolic process | 4.76e-04 | 57 | 235 | 5 | GO:0006692 | |
| GeneOntologyBiologicalProcess | ketone biosynthetic process | 4.76e-04 | 57 | 235 | 5 | GO:0042181 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | DPF1 PIDD1 CUL7 MDM2 HNF4A RPTOR CRLF3 FBXO7 NLE1 CACNB4 TTC28 GTSE1 SLFN12 PBRM1 SMARCB1 SLFN11 PRKDC | 4.91e-04 | 594 | 235 | 17 | GO:0007346 |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 5.18e-04 | 33 | 235 | 4 | GO:0033119 | |
| GeneOntologyBiologicalProcess | mitotic G1 DNA damage checkpoint signaling | 5.82e-04 | 34 | 235 | 4 | GO:0031571 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 5.82e-04 | 34 | 235 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | mitotic G1/S transition checkpoint signaling | 5.82e-04 | 34 | 235 | 4 | GO:0044819 | |
| GeneOntologyBiologicalProcess | rescue of stalled ribosome | 5.82e-04 | 34 | 235 | 4 | GO:0072344 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 7.27e-04 | 36 | 235 | 4 | GO:0034694 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 7.27e-04 | 36 | 235 | 4 | GO:0008299 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle phase transition | DPF1 PIDD1 MDM2 RPTOR CRLF3 FBXO7 CACNB4 GTSE1 SLFN12 PBRM1 SMARCB1 SLFN11 PRKDC | 7.49e-04 | 402 | 235 | 13 | GO:1901990 |
| GeneOntologyBiologicalProcess | response to nutrient levels | LRRK2 MDM2 MAP3K5 RPTOR ABCC8 FES SIK2 GCN1 COMT PPM1D OR4M1 CASR CUBN PRKAG3 OR4M2 SCAP | 8.16e-04 | 566 | 235 | 16 | GO:0031667 |
| GeneOntologyBiologicalProcess | translational elongation | 8.55e-04 | 97 | 235 | 6 | GO:0006414 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | DPF1 PIDD1 MDM2 RPTOR CRLF3 FBXO7 CACNB4 PPM1D GTSE1 SLFN12 PBRM1 CSF1R SMARCB1 CCAR2 SLFN11 PRKDC DOT1L | 8.94e-04 | 627 | 235 | 17 | GO:0044770 |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 8.94e-04 | 38 | 235 | 4 | GO:0048384 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle phase transition | PIDD1 MDM2 CRLF3 FBXO7 CACNB4 GTSE1 SLFN12 CCAR2 SLFN11 PRKDC DOT1L | 9.24e-04 | 311 | 235 | 11 | GO:1901988 |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle | PIDD1 NUBP1 MDM2 HNF4A CRLF3 FBXO7 NLE1 CACNB4 GTSE1 SLFN12 CCAR2 SLFN11 PRKDC DOT1L | 9.28e-04 | 464 | 235 | 14 | GO:0045786 |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle phase transition | 9.50e-04 | 219 | 235 | 9 | GO:1901991 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | LRRK2 MDM2 HNF4A CIZ1 KPNB1 KPNA3 KPNA5 CACNB4 NUP98 IPO4 TESK1 LIMK2 | 9.62e-04 | 362 | 235 | 12 | GO:0034504 |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | PIDD1 NUBP1 MDM2 CRLF3 FBXO7 CACNB4 GTSE1 SLFN12 CCAR2 SLFN11 PRKDC DOT1L | 9.62e-04 | 362 | 235 | 12 | GO:0010948 |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 1.09e-03 | 40 | 235 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | response to estrogen | 1.17e-03 | 103 | 235 | 6 | GO:0043627 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 1.18e-03 | 141 | 235 | 7 | GO:0006805 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 1.23e-03 | 142 | 235 | 7 | GO:0006690 | |
| GeneOntologyBiologicalProcess | ribosome disassembly | 1.31e-03 | 42 | 235 | 4 | GO:0032790 | |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 1.31e-03 | 42 | 235 | 4 | GO:0071398 | |
| GeneOntologyBiologicalProcess | regulation of steroid biosynthetic process | 1.36e-03 | 106 | 235 | 6 | GO:0050810 | |
| MousePheno | hypermyelination | 1.95e-07 | 11 | 191 | 5 | MP:0010050 | |
| MousePheno | abnormal gestational length | 3.35e-06 | 18 | 191 | 5 | MP:0002292 | |
| MousePheno | parturition failure | 6.65e-06 | 10 | 191 | 4 | MP:0012010 | |
| MousePheno | increased oligodendrocyte number | 2.19e-05 | 13 | 191 | 4 | MP:0010160 | |
| MousePheno | increased circulating progesterone level | 4.10e-05 | 15 | 191 | 4 | MP:0005186 | |
| MousePheno | long stride length | 4.10e-05 | 15 | 191 | 4 | MP:0010540 | |
| MousePheno | long gestation period | 4.10e-05 | 15 | 191 | 4 | MP:0002293 | |
| MousePheno | prolonged diestrus | 4.88e-05 | 30 | 191 | 5 | MP:0009011 | |
| MousePheno | abnormal diestrus | 1.05e-04 | 35 | 191 | 5 | MP:0009010 | |
| MousePheno | abnormal left-right axis symmetry of the somites | 1.34e-04 | 8 | 191 | 3 | MP:0005224 | |
| MousePheno | dysmyelination | 1.38e-04 | 20 | 191 | 4 | MP:0013438 | |
| MousePheno | enhanced coordination | 1.57e-04 | 38 | 191 | 5 | MP:0003858 | |
| MousePheno | prolonged estrous cycle | 1.78e-04 | 39 | 191 | 5 | MP:0009006 | |
| Domain | ARM-like | ARMC3 LRRK2 PSMD2 CUL7 AP2A1 RPTOR AP5Z1 AP1G2 BRAT1 GCN1 KPNB1 KPNA3 KPNA5 HEATR4 NBEA HEATR5A IPO4 MEI1 SPAG6 RSPRY1 PPP2R1A MROH6 PRKDC | 3.39e-13 | 270 | 230 | 23 | IPR011989 |
| Domain | ARM-type_fold | ARMC3 LRRK2 INTS1 PSMD2 CUL7 AP2A1 PIK3CD RPTOR AP1G2 BRAT1 GCN1 UNC79 KPNB1 KPNA3 KPNA5 HEATR4 NBEA HEATR5A IPO4 MEI1 SPAG6 RSPRY1 PPP2R1A MROH6 PRKDC | 7.83e-13 | 339 | 230 | 25 | IPR016024 |
| Domain | - | ARMC3 LRRK2 PSMD2 CUL7 AP2A1 RPTOR AP5Z1 AP1G2 BRAT1 GCN1 KPNB1 KPNA3 KPNA5 HEATR4 HEATR5A IPO4 SPAG6 PPP2R1A MROH6 PRKDC | 4.50e-12 | 222 | 230 | 20 | 1.25.10.10 |
| Domain | HEAT | 6.15e-09 | 48 | 230 | 9 | PF02985 | |
| Domain | HEAT | 3.51e-08 | 58 | 230 | 9 | IPR000357 | |
| Domain | - | 1.06e-06 | 16 | 230 | 5 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 1.49e-06 | 17 | 230 | 5 | IPR023210 | |
| Domain | Aldo_ket_red | 1.49e-06 | 17 | 230 | 5 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 1.49e-06 | 17 | 230 | 5 | IPR001395 | |
| Domain | HEAT_REPEAT | 2.29e-06 | 70 | 230 | 8 | PS50077 | |
| Domain | ALDOKETO_REDUCTASE_1 | 4.44e-06 | 10 | 230 | 4 | PS00798 | |
| Domain | ALDOKETO_REDUCTASE_2 | 4.44e-06 | 10 | 230 | 4 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 4.44e-06 | 10 | 230 | 4 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 4.44e-06 | 10 | 230 | 4 | IPR018170 | |
| Domain | Aldo/keto_reductase | 4.44e-06 | 10 | 230 | 4 | IPR020471 | |
| Domain | ARM | 8.84e-06 | 40 | 230 | 6 | SM00185 | |
| Domain | Armadillo | 2.30e-05 | 47 | 230 | 6 | IPR000225 | |
| Domain | Arm | 3.55e-05 | 31 | 230 | 5 | PF00514 | |
| Domain | HEAT_type_2 | 4.70e-05 | 17 | 230 | 4 | IPR021133 | |
| Domain | AlbA_2 | 6.22e-05 | 7 | 230 | 3 | PF04326 | |
| Domain | Schlafen | 6.22e-05 | 7 | 230 | 3 | IPR029684 | |
| Domain | Schlafen_AAA_dom | 6.22e-05 | 7 | 230 | 3 | IPR007421 | |
| Domain | Alpha_adaptinC2 | 1.47e-04 | 9 | 230 | 3 | PF02883 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 1.47e-04 | 9 | 230 | 3 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 1.47e-04 | 9 | 230 | 3 | SM00809 | |
| Domain | Spt20 | 1.51e-04 | 2 | 230 | 2 | IPR021950 | |
| Domain | Sulphorea_rcpt | 1.51e-04 | 2 | 230 | 2 | IPR000388 | |
| Domain | Spt20 | 1.51e-04 | 2 | 230 | 2 | PF12090 | |
| Domain | AT_hook | 3.15e-04 | 27 | 230 | 4 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 3.15e-04 | 27 | 230 | 4 | IPR017956 | |
| Domain | Coatomer/clathrin_app_Ig-like | 3.74e-04 | 12 | 230 | 3 | IPR013041 | |
| Domain | DUF2075 | 4.49e-04 | 3 | 230 | 2 | PF09848 | |
| Domain | DUF2075 | 4.49e-04 | 3 | 230 | 2 | IPR018647 | |
| Domain | Neurofascin/L1/NrCAM_C | 8.91e-04 | 4 | 230 | 2 | IPR026966 | |
| Domain | Bravo_FIGEY | 8.91e-04 | 4 | 230 | 2 | PF13882 | |
| Domain | - | LRRK2 NUBP1 SRCAP DNAH14 GSPT2 DQX1 ABCC8 ASCC3 ABCC1 CACNB4 SEPTIN5 RNF213 ABCC9 CHD1L HELQ EEF1A1 DNAH1 SLFN13 N4BP2 SLFN11 | 9.54e-04 | 746 | 230 | 20 | 3.40.50.300 |
| Domain | ARM_REPEAT | 1.45e-03 | 40 | 230 | 4 | PS50176 | |
| Domain | NUT | 1.47e-03 | 5 | 230 | 2 | IPR024310 | |
| Domain | NUT_N | 1.47e-03 | 5 | 230 | 2 | IPR024309 | |
| Domain | GAE | 1.47e-03 | 5 | 230 | 2 | PS50180 | |
| Domain | NUT | 1.47e-03 | 5 | 230 | 2 | PF12881 | |
| Domain | - | CHL1 LRRC24 SIRPB2 VSTM4 CRLF3 ASTN2 PLXNA3 NRCAM RELB VSIG10 MST1R TGM3 CSF1R SIGLEC6 NCAN SIGLEC1 FNDC8 ANKFN1 | 1.49e-03 | 663 | 230 | 18 | 2.60.40.10 |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 2.02e-06 | 9 | 162 | 4 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 2.02e-06 | 9 | 162 | 4 | M47817 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 5.21e-06 | 11 | 162 | 4 | M47812 | |
| Pathway | REACTOME_PREDNISONE_ADME | 5.36e-06 | 23 | 162 | 5 | MM16639 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 1.11e-05 | 13 | 162 | 4 | MM14747 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 1.11e-05 | 13 | 162 | 4 | M17842 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 1.54e-05 | 14 | 162 | 4 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.54e-05 | 14 | 162 | 4 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 1.54e-05 | 14 | 162 | 4 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.54e-05 | 14 | 162 | 4 | MM14748 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 2.08e-05 | 15 | 162 | 4 | MM14870 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 3.82e-05 | 55 | 162 | 6 | M14933 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.25e-04 | 23 | 162 | 4 | MM14741 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.25e-04 | 23 | 162 | 4 | M1926 | |
| Pathway | WP_THERMOGENESIS | 2.45e-04 | 108 | 162 | 7 | M39746 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 2.77e-04 | 28 | 162 | 4 | MM15188 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 ALKBH4 LRRC24 PPRC1 INTS1 SRCAP BIRC6 MAP3K5 GGA3 TPCN1 ZCCHC14 AP2A1 PIK3CD RPTOR MCM3AP AP1G2 NLE1 CACNA1H BRAT1 GCN1 SMURF2 PLXNA3 DPH2 PNPLA2 GTSE1 HECTD4 RELB SMG5 HES2 TESK1 FAAP100 MST1R SCAP MROH6 NAPRT KANK3 PRKDC DOT1L | 3.86e-16 | 1105 | 241 | 38 | 35748872 |
| Pubmed | DPF1 TRIML1 IL16 POGZ CUL7 SRCAP MDM2 PLEKHN1 TRIM66 RPTOR MCM3AP CIZ1 XRN1 ASCC3 KPNA3 SUPT20H TTC28 KDM5A KIAA1549 RNF213 NCKAP5L SLC4A1 TUBGCP6 LIMK2 PBRM1 BAZ2A NT5DC2 TCF25 SMARCB1 SIGLEC1 SLFN11 | 5.92e-11 | 1116 | 241 | 31 | 31753913 | |
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 10393440 | ||
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 2.25e-09 | 4 | 241 | 4 | 31479646 | |
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 10702227 | ||
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 17442338 | ||
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 28329705 | ||
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 16511129 | ||
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 15222881 | ||
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 10526179 | ||
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 21521174 | ||
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 8274401 | ||
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 2.25e-09 | 4 | 241 | 4 | 34590152 | |
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 2.25e-09 | 4 | 241 | 4 | 10500239 | |
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 2.25e-09 | 4 | 241 | 4 | 14967952 | |
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 2.25e-09 | 4 | 241 | 4 | 15193432 | |
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 16191478 | ||
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 15577209 | ||
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 17034817 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 2.25e-09 | 4 | 241 | 4 | 29764944 | |
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 17888864 | ||
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 19237748 | ||
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 28259989 | ||
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 7789999 | ||
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 20124700 | ||
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 2.25e-09 | 4 | 241 | 4 | 16508162 | |
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 17629694 | ||
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 16018803 | ||
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 17272929 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 2.25e-09 | 4 | 241 | 4 | 18667791 | |
| Pubmed | NCKAP1 PPRC1 POGZ USP19 GGA3 ZCCHC14 MCM3AP CACNA1H BAIAP3 NRCAM TTC28 HEATR5A BAZ2A SPHKAP TCF25 CCAR2 R3HDM1 | 4.70e-09 | 407 | 241 | 17 | 12693553 | |
| Pubmed | PPRC1 VPS45 PSMD2 POGZ TRIM66 AP2A1 NGEF FBXO7 ASTN2 SMURF2 RECK KPNB1 KPNA3 ATRN SUPT20H NRCAM TTC28 KDM5A HECTD4 NBEA SMG5 IDS EEF1A1 FBXL16 CIAO3 AKR1C3 PRKDC CKAP2 R3HDM1 ABHD12 | 7.07e-09 | 1285 | 241 | 30 | 35914814 | |
| Pubmed | NCKAP1 INTS1 PSMD2 POGZ CUL7 BIRC6 MCM3AP XRN1 ALDH18A1 NLE1 ASCC3 GCN1 KPNB1 NUP98 IPO4 TGM3 PPP2R1A PBRM1 BAZ2A CCAR2 PRKDC | 7.26e-09 | 653 | 241 | 21 | 22586326 | |
| Pubmed | 1.12e-08 | 5 | 241 | 4 | 7737980 | ||
| Pubmed | 1.12e-08 | 5 | 241 | 4 | 38788959 | ||
| Pubmed | 1.12e-08 | 5 | 241 | 4 | 18003893 | ||
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 1.12e-08 | 5 | 241 | 4 | 21851338 | |
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 1.12e-08 | 5 | 241 | 4 | 16984997 | |
| Pubmed | 1.12e-08 | 5 | 241 | 4 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 1.12e-08 | 5 | 241 | 4 | 17064890 | |
| Pubmed | 1.12e-08 | 5 | 241 | 4 | 10672042 | ||
| Pubmed | 1.89e-08 | 13 | 241 | 5 | 11682476 | ||
| Pubmed | 3.34e-08 | 6 | 241 | 4 | 19273550 | ||
| Pubmed | 3.34e-08 | 6 | 241 | 4 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 3.34e-08 | 6 | 241 | 4 | 26748576 | |
| Pubmed | 3.34e-08 | 6 | 241 | 4 | 17122075 | ||
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 3.34e-08 | 6 | 241 | 4 | 29107092 | |
| Pubmed | 3.34e-08 | 6 | 241 | 4 | 15860270 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 3.34e-08 | 6 | 241 | 4 | 17255200 | |
| Pubmed | PSMD2 GSDME AP2A1 AP1G2 GCN1 KPNB1 RNF213 IPO4 EEF1A1 PPP2R1A PRKDC | 7.03e-08 | 183 | 241 | 11 | 23956138 | |
| Pubmed | NCKAP1 LRRC24 MAP3K5 AP2A1 RPTOR NGEF KCNAB1 UNC79 KPNB1 CACNB4 NRCAM SEPTIN5 KDM5A HECTD4 ARHGEF18 NBEA IPO4 EEF1A1 PPP2R1A PBRM1 N4BP2 SPHKAP NCAN CCAR2 | 7.66e-08 | 963 | 241 | 24 | 28671696 | |
| Pubmed | 7.74e-08 | 7 | 241 | 4 | 33127481 | ||
| Pubmed | 7.74e-08 | 7 | 241 | 4 | 12562828 | ||
| Pubmed | 7.74e-08 | 7 | 241 | 4 | 22529366 | ||
| Pubmed | 7.74e-08 | 7 | 241 | 4 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 7.74e-08 | 7 | 241 | 4 | 34843575 | |
| Pubmed | 7.74e-08 | 7 | 241 | 4 | 16337335 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FAM120B DIS3L2 NCKAP1 PSMD2 POGZ SRCAP BIRC6 AP2A1 RPTOR MCM3AP XRN1 ALDH18A1 AP1G2 NLE1 ASCC3 CORO7 GCN1 PARP12 KPNB1 KPNA3 COMT CHD1L IPO4 TGM3 PPP2R1A BAZ2A TK1 CCAR2 PRKDC | 8.06e-08 | 1353 | 241 | 29 | 29467282 |
| Pubmed | 1.54e-07 | 8 | 241 | 4 | 18187047 | ||
| Pubmed | 1.54e-07 | 8 | 241 | 4 | 20837989 | ||
| Pubmed | 1.54e-07 | 8 | 241 | 4 | 33584538 | ||
| Pubmed | 1.54e-07 | 8 | 241 | 4 | 9224647 | ||
| Pubmed | 2.76e-07 | 9 | 241 | 4 | 33348080 | ||
| Pubmed | 3.29e-07 | 3 | 241 | 3 | 19320734 | ||
| Pubmed | 3.29e-07 | 3 | 241 | 3 | 21232532 | ||
| Pubmed | 3.29e-07 | 3 | 241 | 3 | 24220028 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 3.29e-07 | 3 | 241 | 3 | 31780644 | |
| Pubmed | 3.29e-07 | 3 | 241 | 3 | 13678667 | ||
| Pubmed | 3.29e-07 | 3 | 241 | 3 | 7626489 | ||
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 4.57e-07 | 10 | 241 | 4 | 36313771 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | INTS1 AKR1C2 XRN1 GCN1 KPNA5 SEPTIN5 HSPA4L NBEA IPO4 EEF1A1 PPP2R1A PBRM1 NAPRT NT5DC2 SMARCB1 ABHD12 | 4.80e-07 | 498 | 241 | 16 | 36634849 |
| Pubmed | 7.14e-07 | 11 | 241 | 4 | 22509482 | ||
| Pubmed | 7.40e-07 | 105 | 241 | 8 | 9628581 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NCKAP1 PSMD2 NDUFA2 USP19 AP2A1 RPTOR ASCC3 CORO7 BRAT1 GCN1 KPNB1 FKBP10 ABCC1 HSPA4L NUP98 IPO4 SPAG5 PPP2R1A SCAP TCF25 PRKDC ABHD12 | 8.11e-07 | 942 | 241 | 22 | 31073040 |
| Pubmed | FAM120B IL16 NCKAP1 VPS45 PSMD2 NDUFA2 AP2A1 RPTOR NGEF XRN1 CORO7 KPNB1 KPNA3 CACNB4 NRCAM NRDC SEPTIN5 HSPA4L NCKIPSD KIAA1549 NBEA SLC4A1 EEF1A1 PPP2R1A FBXL16 NCAN PCDH1 ABHD12 | 8.48e-07 | 1431 | 241 | 28 | 37142655 | |
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 1.07e-06 | 12 | 241 | 4 | 21256921 | |
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 1.07e-06 | 12 | 241 | 4 | 28893949 | |
| Pubmed | 1.07e-06 | 12 | 241 | 4 | 25774556 | ||
| Pubmed | INTS1 YTHDC1 BIRC6 ASCC3 GCN1 UNC79 KPNB1 KPNA3 TTC28 NUP98 PPP2R1A PBRM1 N4BP2 SMARCB1 CCAR2 | 1.16e-06 | 469 | 241 | 15 | 27634302 | |
| Pubmed | PSMD2 CUL7 BIRC6 CRLF3 ALDH18A1 GCN1 KPNB1 KPNA3 ABCC1 ELOA PPM1D NUP98 KIAA1549 RNF213 NBEA FAM171B NCKAP5L PPP2R1A FBXL16 CCAR2 SLFN11 CKAP2 PHLPP2 | 1.32e-06 | 1049 | 241 | 23 | 27880917 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | PSMD2 AP2A1 PTRH1 XRN1 ASCC3 CORO7 GCN1 KPNB1 KPNA5 FKBP10 NRDC HSPA4L NUP98 IPO4 NCKAP5L FAAP100 PPP2R1A TK1 NT5DC2 CCAR2 PRKDC ABHD12 | 1.40e-06 | 974 | 241 | 22 | 28675297 |
| Pubmed | 1.44e-06 | 51 | 241 | 6 | 11853319 | ||
| Pubmed | 1.53e-06 | 13 | 241 | 4 | 24580729 | ||
| Pubmed | A link between lung androgen metabolism and the emergence of mature epithelial type II cells. | 1.53e-06 | 13 | 241 | 4 | 15117747 | |
| Pubmed | 1.53e-06 | 13 | 241 | 4 | 17062636 | ||
| Pubmed | 2.13e-06 | 14 | 241 | 4 | 19955443 | ||
| Pubmed | Placental endocrine function shapes cerebellar development and social behavior. | 2.13e-06 | 14 | 241 | 4 | 34400844 | |
| Pubmed | 2.56e-06 | 87 | 241 | 7 | 33711283 | ||
| Pubmed | INTS1 PIDD1 PSMD2 CUL7 RECK KPNB1 THOC1 COMT IPO4 MARF1 PRKDC HDAC10 | 2.97e-06 | 322 | 241 | 12 | 26514267 | |
| Pubmed | 3.25e-06 | 5 | 241 | 3 | 15212687 | ||
| Pubmed | 3.25e-06 | 5 | 241 | 3 | 24089532 | ||
| Pubmed | 3.25e-06 | 5 | 241 | 3 | 15929992 | ||
| Pubmed | 3.25e-06 | 5 | 241 | 3 | 18355440 | ||
| Pubmed | 3.25e-06 | 5 | 241 | 3 | 29528433 | ||
| Pubmed | NCKAP1 CUL7 BIRC6 AP2A1 CRLF3 ALDH18A1 TTC28 NCKIPSD KIAA1549 NCKAP5L PPP2R1A FBXL16 PRKDC R3HDM1 | 3.30e-06 | 446 | 241 | 14 | 24255178 | |
| Pubmed | 3.51e-06 | 129 | 241 | 8 | 23022380 | ||
| Pubmed | 4.99e-06 | 17 | 241 | 4 | 32243503 | ||
| Pubmed | 5.57e-06 | 37 | 241 | 5 | 21362171 | ||
| Interaction | TOP3B interactions | VWA5B2 ALKBH4 LRRC24 PPRC1 INTS1 SRCAP BIRC6 MAP3K5 GGA3 TPCN1 ZCCHC14 AP2A1 PIK3CD RPTOR MCM3AP XRN1 AP1G2 NLE1 CACNA1H BRAT1 GCN1 SMURF2 THOC1 PLXNA3 DPH2 PNPLA2 GTSE1 HECTD4 RELB SMG5 IPO4 HES2 TESK1 FAAP100 MST1R SCAP MROH6 NAPRT KANK3 PRKDC DOT1L | 5.66e-08 | 1470 | 227 | 41 | int:TOP3B |
| Interaction | BAG2 interactions | VWA5B2 RPS6KB2 LRRK2 CUL7 TRIM66 RBM27 RPTOR AP5Z1 CIZ1 FBXO7 SIK2 MINDY4 ASCC3 DPH2 TUBGCP6 LIMK2 SHROOM1 CCAR2 CKAP2 DOT1L R3HDM1 MAP2K5 EPAS1 | 6.30e-07 | 622 | 227 | 23 | int:BAG2 |
| Interaction | AKR1C4 interactions | 1.06e-06 | 8 | 227 | 4 | int:AKR1C4 | |
| Interaction | HIF1A interactions | BHLHE41 LRRK2 MDM2 HNF4A USP19 RPTOR GCN1 SMURF2 KPNA3 KPNA5 CASR PPP2R1A FBXL16 CCAR2 PRKDC MAP2K5 EPAS1 | 1.14e-05 | 441 | 227 | 17 | int:HIF1A |
| Interaction | EGLN3 interactions | FAM120B VPS45 NUBP1 PSMD2 MDM2 BIRC6 MAP3K5 ZCCHC14 HROB RBM27 RPTOR PARL XRN1 SIK2 ALDH18A1 GCN1 KPNB1 KPNA3 NRDC GTSE1 SMG5 CHD1L IPO4 TUBGCP6 PPP2R1A NT5DC2 N4BP2 TCF25 PRKDC R3HDM1 ABHD12 EPAS1 | 2.39e-05 | 1296 | 227 | 32 | int:EGLN3 |
| Interaction | LATS2 interactions | CUL7 MDM2 MAP3K5 ALDH18A1 HERC6 GCN1 HSPA4L KIAA1549 NCKAP5L PPP2R1A FBXL16 PRKDC MAP2K5 | 2.59e-05 | 289 | 227 | 13 | int:LATS2 |
| Interaction | SIRT7 interactions | NCKAP1 INTS1 PSMD2 POGZ CUL7 MDM2 BIRC6 MCM3AP XRN1 ALDH18A1 NLE1 ASCC3 GCN1 KPNB1 NUP98 IPO4 TGM3 PPP2R1A PBRM1 BAZ2A CCAR2 PRKDC | 3.78e-05 | 744 | 227 | 22 | int:SIRT7 |
| Cytoband | 10p15-p14 | 2.90e-06 | 6 | 243 | 3 | 10p15-p14 | |
| Cytoband | 2q32 | 5.11e-05 | 14 | 243 | 3 | 2q32 | |
| Cytoband | 17q12 | 1.90e-04 | 99 | 243 | 5 | 17q12 | |
| Cytoband | 10p12.31 | 2.09e-04 | 22 | 243 | 3 | 10p12.31 | |
| Cytoband | 12q24.13 | 3.09e-04 | 25 | 243 | 3 | 12q24.13 | |
| Cytoband | 15q15.3 | 3.09e-04 | 25 | 243 | 3 | 15q15.3 | |
| Cytoband | 3q27.1 | 3.90e-04 | 27 | 243 | 3 | 3q27.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20p13 | 5.19e-04 | 123 | 243 | 5 | chr20p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | 1.23e-03 | 149 | 243 | 5 | chr17q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p15 | 1.37e-03 | 90 | 243 | 4 | chr10p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 1.57e-03 | 316 | 243 | 7 | chr3p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 2.09e-03 | 426 | 243 | 8 | chr16p13 | |
| Cytoband | 20p13 | 2.17e-03 | 102 | 243 | 4 | 20p13 | |
| GeneFamily | Aldo-keto reductases | 1.14e-07 | 15 | 153 | 5 | 399 | |
| GeneFamily | Armadillo repeat containing|Importins | 1.38e-05 | 18 | 153 | 4 | 596 | |
| GeneFamily | Schlafen family | 2.03e-05 | 7 | 153 | 3 | 1110 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.02e-05 | 43 | 153 | 5 | 409 | |
| GeneFamily | ATP binding cassette subfamily C | 1.60e-04 | 13 | 153 | 3 | 807 | |
| GeneFamily | Fibronectin type III domain containing | 2.42e-03 | 160 | 153 | 6 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.50e-03 | 161 | 153 | 6 | 593 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 2.66e-03 | 163 | 153 | 6 | 590 | |
| Coexpression | GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP | CHL1 SRCAP YTHDC1 GCN1 BAIAP3 HSPA4L NPEPL1 SCAP CIAO3 NAPRT MARF1 | 2.67e-06 | 200 | 241 | 11 | M9391 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | SUPT20HL1 AFTPH NCKAP1 SUPT20HL2 AKR1C4 MDM2 SNAI3 AKR1C1 AKR1C2 MAP3K5 DLEC1 KPNB1 KPNA3 ELOA SUPT20H NRDC KDM5A HSPA4L SMG5 CHD1L RSPRY1 PPP2R1A PBRM1 LRRC25 AKR1C3 ABHD12 | 7.02e-06 | 1072 | 241 | 26 | MM1031 |
| Coexpression | GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN | ADGRB1 PIDD1 SRCAP USP19 GGA3 VSTM4 NLE1 CORO7 RNF186 ADAMTS13 | 1.35e-05 | 194 | 241 | 10 | M5767 |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 1.51e-05 | 17 | 241 | 4 | MM826 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_UP | LRRK2 GALNT16 GSPT2 THOC1 PLXNA3 TCTE1 CUBN HELQ BAZ2A SMARCB1 | 1.75e-05 | 200 | 241 | 10 | M3964 |
| Coexpression | ZAMORA_NOS2_TARGETS_DN | 1.85e-05 | 89 | 241 | 7 | MM690 | |
| Coexpression | DESCARTES_ORGANOGENESIS_INTERMEDIATE_MESODERM | 1.88e-05 | 36 | 241 | 5 | MM3660 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP | 2.16e-05 | 37 | 241 | 5 | MM630 | |
| Coexpression | MIKKELSEN_MCV6_LCP_WITH_H3K4ME3 | 3.55e-05 | 174 | 241 | 9 | MM836 | |
| Coexpression | GOLDRATH_IMMUNE_MEMORY | 4.19e-05 | 69 | 241 | 6 | MM621 | |
| Coexpression | JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP | INTS1 PIDD1 MDM2 YTHDC1 AKR1C2 HROB PPM1D RNF213 MYRFL TUBGCP6 NUTM2E N4BP2 EPAS1 | 5.58e-05 | 380 | 241 | 13 | M38974 |
| Coexpression | VARELA_ZMPSTE24_TARGETS_DN | 5.71e-05 | 45 | 241 | 5 | MM1173 | |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 6.41e-05 | 24 | 241 | 4 | MM766 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 7.58e-05 | 25 | 241 | 4 | MM480 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | PPRC1 INTS1 CUL7 SRCAP AP5Z1 SMG5 NCKAP5L NUTM2E LIMK2 CCAR2 HDAC10 DOT1L | 7.59e-05 | 338 | 241 | 12 | M17094 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CHL1 DPF1 NUTM2A LRRK2 ADGRB1 SSPOP AKR1C1 AKR1C2 PIK3CD NGEF UNC79 PLXNA3 CACNB4 KIAA1549 NBEA FAM171B IDS SLC4A1 FBXL16 KLF7 N4BP2 NCAN R3HDM1 PCDH1 | 9.32e-05 | 1106 | 241 | 24 | M39071 |
| Coexpression | GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 1.00e-04 | 199 | 241 | 9 | M313 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_DN | 1.00e-04 | 199 | 241 | 9 | M4997 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_UP | 1.00e-04 | 199 | 241 | 9 | M3857 | |
| Coexpression | GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_UP | 1.00e-04 | 199 | 241 | 9 | M7736 | |
| Coexpression | GSE14308_TH17_VS_INDUCED_TREG_UP | 1.04e-04 | 200 | 241 | 9 | M3385 | |
| Coexpression | GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN | 1.04e-04 | 200 | 241 | 9 | M4667 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_4H_BMDC_DN | 1.04e-04 | 200 | 241 | 9 | M3714 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_DN | 1.32e-04 | 121 | 241 | 7 | MM935 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS | 1.58e-04 | 30 | 241 | 4 | MM853 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_ciliated|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.74e-07 | 174 | 241 | 9 | b8d1c556290d188f56aeefc17f03119686945fe7 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.74e-07 | 174 | 241 | 9 | 00cf27bc23af1472a507be31fba6245a8fdd901b | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.22e-07 | 176 | 241 | 9 | d54543510c804474c5c32e007cd699e75fc5aaba | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.47e-07 | 189 | 241 | 9 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.47e-07 | 189 | 241 | 9 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-06 | 154 | 241 | 8 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-06 | 154 | 241 | 8 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.41e-06 | 176 | 241 | 8 | 4bba41ebf9dd187c8705a6997ed039878de62b4e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.38e-06 | 180 | 241 | 8 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.65e-06 | 181 | 241 | 8 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Lhx1_(Cajal-retzius)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.82e-06 | 85 | 241 | 6 | f9e874ae2b3eadf58fbbe7367c5f498a357166ca | |
| ToppCell | ASK452-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.82e-06 | 85 | 241 | 6 | 523a532e91aa271faab67d0256919b67af2bd7d8 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Lhx1_(Cajal-retzius)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.82e-06 | 85 | 241 | 6 | 2c94ff338633c39edb4a3a69a04be33db764c586 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 6.92e-06 | 182 | 241 | 8 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.92e-06 | 182 | 241 | 8 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.80e-06 | 185 | 241 | 8 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 8.77e-06 | 188 | 241 | 8 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.85e-06 | 191 | 241 | 8 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.85e-06 | 191 | 241 | 8 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.85e-06 | 191 | 241 | 8 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-05 | 198 | 241 | 8 | 7b9c7ce5d6b7df8db85943b65da1a2c202a8bb53 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-05 | 199 | 241 | 8 | 4e0b73d88b1345ec63a9e5629762341e75beb47f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 200 | 241 | 8 | af6a551f83808c1c839df7ba7b1702ca28ea6e1b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Cortical_neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.37e-05 | 200 | 241 | 8 | 19055194a5e0ea122f1b8fc62df44813f6843c95 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 200 | 241 | 8 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 200 | 241 | 8 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-05 | 146 | 241 | 7 | 26493014daa432db721613ef480d133f3da9eb58 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-05 | 151 | 241 | 7 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-05 | 151 | 241 | 7 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.94e-05 | 152 | 241 | 7 | 854c841c1fc6300b7e9be9c98cbf9b0ce2678690 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.02e-05 | 153 | 241 | 7 | 5501095bcf73080872ae01128f21399f9cfc5dd1 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-05 | 154 | 241 | 7 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-05 | 154 | 241 | 7 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-05 | 155 | 241 | 7 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-05 | 155 | 241 | 7 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.29e-05 | 156 | 241 | 7 | e0aef6104be16b12304b8e30358f444c1660e92f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.29e-05 | 156 | 241 | 7 | 5b2781d38a83b4b0f8a53cf321ce5db3a07d0818 | |
| ToppCell | Leuk-UTI-Lymphocyte-B-Plasmablast|Leuk-UTI / Disease, Lineage and Cell Type | 2.49e-05 | 158 | 241 | 7 | 05a29c2d5506a25ccdfa4c6a86e9188977a18272 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.55e-05 | 167 | 241 | 7 | 881f64db8dea3faa7588bf04d87c20924a4e5952 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.83e-05 | 169 | 241 | 7 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.83e-05 | 169 | 241 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.12e-05 | 171 | 241 | 7 | 4f2a83d8091f1fd29542d2e5add57fd482e921b5 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Deuterosomal|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.12e-05 | 171 | 241 | 7 | 52aec5f6677fe2f7a36fb5b18117a4cffaeff58f | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Deuterosomal|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.28e-05 | 172 | 241 | 7 | 08ad76412c9cc3504141797b44b88478ced87476 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 173 | 241 | 7 | 0a0cd40bb5f61431fe34758626c8a63ec610a8a5 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 173 | 241 | 7 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.44e-05 | 173 | 241 | 7 | efb8072475000888efe088d00e870c56ffad4172 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 173 | 241 | 7 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.61e-05 | 174 | 241 | 7 | 58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.78e-05 | 175 | 241 | 7 | 8362a46f5804333baa84cd56d450bc147f372a7e | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.78e-05 | 175 | 241 | 7 | 8b4c62e608f0ec84e563bbf0ebffe3ed44085298 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Cck_(Substantia_Innominata_(SI))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.04e-05 | 74 | 241 | 5 | 7c77b7d84fd8d9d823bbfc586f2b95865e75ab0b | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.04e-05 | 74 | 241 | 5 | b4b961beb98ccf7551bb51773555615586da597d | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.04e-05 | 74 | 241 | 5 | ce00c59e0663093e33317227d31058a08db2d071 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Cck_(Substantia_Innominata_(SI))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.04e-05 | 74 | 241 | 5 | e008982158a3fbade8af9434eb32f20e00f92ba8 | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 5.32e-05 | 178 | 241 | 7 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.32e-05 | 178 | 241 | 7 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.51e-05 | 179 | 241 | 7 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Ciliated|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.91e-05 | 181 | 241 | 7 | 8eed9d46d924b16f6dd1a025ff612244b02b4391 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.12e-05 | 182 | 241 | 7 | c3fb1460160744144aa31afc76c0a4d42ebdeb91 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 6.12e-05 | 182 | 241 | 7 | e44c4810dc7d51a76b86d7623f8e4c4d8b4bf2fc | |
| ToppCell | Pericytes-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.33e-05 | 183 | 241 | 7 | 4617b18da8d699a44e4c47980197b1e7eb951470 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.55e-05 | 184 | 241 | 7 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 185 | 241 | 7 | 2a8104f610fa5ce618f8105521616722462a0d42 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 6.78e-05 | 185 | 241 | 7 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 6.78e-05 | 185 | 241 | 7 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 185 | 241 | 7 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.01e-05 | 186 | 241 | 7 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.25e-05 | 187 | 241 | 7 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | control-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.75e-05 | 189 | 241 | 7 | bdfd120900ba58d5e54765f7b576e1f8cc2401bf | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.75e-05 | 189 | 241 | 7 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 7.75e-05 | 189 | 241 | 7 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-05 | 189 | 241 | 7 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-05 | 189 | 241 | 7 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | SupraBC-Differ-KC|World / shred by cell class for mouse tongue | 7.75e-05 | 189 | 241 | 7 | 6412741b88e241304033b41effca0c77a374d907 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 7.75e-05 | 189 | 241 | 7 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.01e-05 | 190 | 241 | 7 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 190 | 241 | 7 | 719a5cecc3e8001ca9c38165258b5ff9c800713a | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 8.01e-05 | 190 | 241 | 7 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 8.56e-05 | 192 | 241 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.84e-05 | 193 | 241 | 7 | 4fb020f11fd7aff06952bfeaabc79b2c7b8873f6 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 8.84e-05 | 193 | 241 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | medial-2-Hematologic-Nonclassical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.13e-05 | 194 | 241 | 7 | 202e5070728191c46161fa7d931f00be1c7559d4 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.13e-05 | 194 | 241 | 7 | 885355ebe98e974f841cc59dce3b5228c642c5d0 | |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.13e-05 | 194 | 241 | 7 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 | |
| ToppCell | medial-Hematologic-Nonclassical_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.13e-05 | 194 | 241 | 7 | 002cd317732fc6b0d9a72fb46199f71db5a638a7 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.13e-05 | 194 | 241 | 7 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 9.13e-05 | 194 | 241 | 7 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd | |
| ToppCell | medial-Hematologic-Nonclassical_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.13e-05 | 194 | 241 | 7 | ac203d388a3a3884e316dec0dcbd408e43c6ef6c | |
| ToppCell | 21-Trachea-Immune-Hematopoietic,_Macrophage|Trachea / Age, Tissue, Lineage and Cell class | 9.13e-05 | 194 | 241 | 7 | 3c4ac5f91b10802990b84db3406f5e71f8ee8b74 | |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 9.42e-05 | 195 | 241 | 7 | f5597d3ed37770c6fa2b339f98a80ac7ecd4f9ff | |
| ToppCell | 10x5'|World / Manually curated celltypes from each tissue | 9.42e-05 | 195 | 241 | 7 | de28b998793271c4f69ce9e183c3e62d809e9cc8 | |
| ToppCell | Adult-Immune-monocyte-D122|Adult / Lineage, Cell type, age group and donor | 9.73e-05 | 196 | 241 | 7 | 16b0acb6157534938ca83d4e909471e33a7d3c52 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.73e-05 | 196 | 241 | 7 | 84c7f2153b5a9c4da7ae48fdf816a163c33d9a5e | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.73e-05 | 196 | 241 | 7 | 47930de6b47b7bf22d8dae8b7419a9cd1d22f0ea | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 1.00e-04 | 197 | 241 | 7 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.00e-04 | 197 | 241 | 7 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-04 | 197 | 241 | 7 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-04 | 197 | 241 | 7 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.00e-04 | 197 | 241 | 7 | 86591849476b3925857a82b6913f65e74df200c1 | |
| Drug | cloxazolam | 1.09e-08 | 4 | 234 | 4 | ctd:C005522 | |
| Drug | Pregnanes | 1.09e-08 | 4 | 234 | 4 | ctd:D011278 | |
| Drug | tetralol | 1.09e-08 | 4 | 234 | 4 | ctd:C019106 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 1.09e-08 | 4 | 234 | 4 | ctd:C018156 | |
| Drug | Hydroxysteroids | 5.39e-08 | 5 | 234 | 4 | ctd:D006914 | |
| Drug | cresolphthalein | 5.39e-08 | 5 | 234 | 4 | ctd:C010092 | |
| Drug | Medazepam | 1.61e-07 | 6 | 234 | 4 | ctd:D008472 | |
| Drug | Nitrazepam | 7.37e-07 | 8 | 234 | 4 | ctd:D009567 | |
| Drug | cyclopentanol | 1.07e-06 | 3 | 234 | 3 | ctd:C016327 | |
| Drug | cyclopentanone | 1.07e-06 | 3 | 234 | 3 | ctd:C007201 | |
| Drug | 5-dihydrodeoxycorticosterone | 1.07e-06 | 3 | 234 | 3 | ctd:C454687 | |
| Drug | 4-benzoylbenzoic acid | 1.07e-06 | 3 | 234 | 3 | ctd:C058818 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 1.07e-06 | 3 | 234 | 3 | ctd:C530610 | |
| Drug | 4-hydroxybenzoic acid | 1.32e-06 | 9 | 234 | 4 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 1.32e-06 | 9 | 234 | 4 | ctd:D004092 | |
| Drug | octyl gallate | 2.18e-06 | 10 | 234 | 4 | ctd:C016627 | |
| Drug | Dihydroxydihydrobenzopyrenes | 3.39e-06 | 11 | 234 | 4 | ctd:D004101 | |
| Drug | chlordecone alcohol | 3.39e-06 | 11 | 234 | 4 | CID000013946 | |
| Drug | tetrahydrodeoxycorticosterone | 4.25e-06 | 4 | 234 | 3 | ctd:C009413 | |
| Drug | gliquidone | 4.25e-06 | 4 | 234 | 3 | ctd:C010969 | |
| Drug | DBD-H | 4.25e-06 | 4 | 234 | 3 | CID000131382 | |
| Drug | Phenolphthalein | 5.05e-06 | 12 | 234 | 4 | ctd:D020113 | |
| Drug | Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A | PIDD1 SRCAP MDM2 SIK2 BAIAP3 PNPLA2 FMOD COMT RELB SMG5 PCDH1 | 5.94e-06 | 195 | 234 | 11 | 2833_UP |
| Drug | Moxonidine [75438-57-2]; Down 200; 16.6uM; HL60; HT_HG-U133A | BHLHE41 PIDD1 TPCN1 AP5Z1 RELB IDS FAAP100 PEX26 CSF1R MAP2K5 EPAS1 | 6.23e-06 | 196 | 234 | 11 | 2923_DN |
| Drug | Glycocholic acid [475-31-0]; Up 200; 8.6uM; MCF7; HT_HG-U133A | MDM2 HNF4A ZCCHC14 HROB KCNAB1 CACNA1H BAIAP3 KDM5A RELB CSF1R MAP2K5 | 6.23e-06 | 196 | 234 | 11 | 3315_UP |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; MCF7; HT_HG-U133A | INTS1 PIDD1 SRCAP MDM2 ZCCHC14 DLC1 ASTN2 HERC6 TESK1 KLF7 AKR1C3 | 6.87e-06 | 198 | 234 | 11 | 6263_UP |
| Drug | DMBA-3,4-dihydrodiol | 7.23e-06 | 13 | 234 | 4 | CID000050096 | |
| Drug | flunisolide | 7.23e-06 | 13 | 234 | 4 | ctd:C007734 | |
| Drug | 5-alpha-Dihydroprogesterone | 1.00e-05 | 14 | 234 | 4 | ctd:D043582 | |
| Drug | 1-acenaphthenol | 1.00e-05 | 14 | 234 | 4 | CID000022750 | |
| Drug | Meclofenamic Acid | 1.00e-05 | 14 | 234 | 4 | ctd:D008469 | |
| Drug | NSC86000 | 1.06e-05 | 5 | 234 | 3 | CID000257630 | |
| Drug | Withaferin A [5119-48-2]; Up 200; 1uM; MCF7; HT_HG-U133A | INTS1 HROB PIK3CD CACNA1H UPK3A HSPA4L CASR MST1R AKR1C3 PHLPP2 | 1.80e-05 | 180 | 234 | 10 | 4376_UP |
| Drug | AC1L93E5 | 2.10e-05 | 6 | 234 | 3 | CID000412383 | |
| Drug | SImax | 2.10e-05 | 6 | 234 | 3 | CID005371578 | |
| Drug | Estazolam | 2.10e-05 | 6 | 234 | 3 | ctd:D004949 | |
| Drug | 3-hydroxyhexobarbital | 2.10e-05 | 6 | 234 | 3 | CID000439898 | |
| Drug | Glipizide | 2.10e-05 | 6 | 234 | 3 | ctd:D005913 | |
| Drug | acenaphthene-1-ol | 2.10e-05 | 6 | 234 | 3 | ctd:C023723 | |
| Drug | phenolphthalein | 2.86e-05 | 58 | 234 | 6 | CID000004764 | |
| Drug | Glyburide | 2.86e-05 | 58 | 234 | 6 | ctd:D005905 | |
| Drug | silver iodide | 2.86e-05 | 58 | 234 | 6 | CID000024563 | |
| Drug | 5230742; Up 200; 17uM; MCF7; HT_HG-U133A_EA | INPP1 MDM2 DLC1 ASB6 AP5Z1 CACNA1H PLXNA3 FKBP10 PNPLA2 SMG5 | 2.87e-05 | 190 | 234 | 10 | 970_UP |
| Drug | cloxazolam | 2.97e-05 | 18 | 234 | 4 | CID000002816 | |
| Drug | Ruthenium Compounds | 2.97e-05 | 18 | 234 | 4 | ctd:D017975 | |
| Drug | 5194442; Up 200; 20uM; PC3; HT_HG-U133A | ALKBH4 PIDD1 MDM2 TRIM66 AP5Z1 ASTN2 SMG5 NPEPL1 CARD8 AKR1C3 | 3.43e-05 | 194 | 234 | 10 | 6553_UP |
| Drug | Methyldopa (L,-) [555-30-6]; Up 200; 19uM; HL60; HG-U133A | POGZ SRCAP TRIM66 PARP12 KDM5A ADAMTS13 IDS SLC4A1 BAZ2A MAP2K5 | 3.58e-05 | 195 | 234 | 10 | 1619_UP |
| Drug | 4-hydroxyequilenin-o-quinone | 3.64e-05 | 7 | 234 | 3 | ctd:C117714 | |
| Drug | zomepirac | 3.64e-05 | 7 | 234 | 3 | ctd:C020549 | |
| Drug | oxcarbazepine | 3.73e-05 | 19 | 234 | 4 | ctd:C036006 | |
| Drug | Hesperetin [520-33-2]; Up 200; 13.2uM; HL60; HG-U133A | 3.74e-05 | 196 | 234 | 10 | 2031_UP | |
| Drug | 9,10-phenanthrenequinone | 3.83e-05 | 61 | 234 | 6 | CID000006763 | |
| Drug | Tocainide hydrochloride; Down 200; 17.4uM; HL60; HT_HG-U133A | 3.91e-05 | 197 | 234 | 10 | 2931_DN | |
| Drug | Lobeline alpha (-) hydrochoride [134-63-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A | RPS6KB2 SRCAP SIK2 PARP12 PNPLA2 SUPT20H GTSE1 NUP98 IDS MAP2K5 | 3.91e-05 | 197 | 234 | 10 | 2763_DN |
| Drug | Chloroquine diphosphate [50-63-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | BHLHE41 SRCAP ABCC8 KCNAB1 AP1G2 CACNA1H BAIAP3 PARP12 FKBP10 ADAMTS13 | 3.91e-05 | 197 | 234 | 10 | 2869_UP |
| Drug | Molsidomine [25717-80-0]; Down 200; 16.6uM; HL60; HG-U133A | TRIM66 GSDME AP5Z1 CIZ1 AP1G2 ABCC1 SUPT20H NUP98 FAAP100 MAP2K5 | 3.91e-05 | 197 | 234 | 10 | 1711_DN |
| Drug | deferoxamine mesylate salt; Down 200; 100uM; PC3; HG-U133A | ALKBH4 LCMT2 DLC1 MCM3AP FKBP10 SUPT20H GTSE1 NUP98 CHD1L FAAP100 | 3.91e-05 | 197 | 234 | 10 | 460_DN |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A | PIDD1 SRCAP USP19 ZCCHC14 DLC1 KPNA5 FKBP10 COMT ADAMTS13 BAZ2A | 3.91e-05 | 197 | 234 | 10 | 3939_DN |
| Drug | Roxarsone [121-19-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A | NDUFA2 SRCAP TPCN1 PIK3CD CIZ1 FKBP10 ABCC1 PNPLA2 CSF1R ARSD | 4.08e-05 | 198 | 234 | 10 | 5470_UP |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; MCF7; HT_HG-U133A | PIDD1 TPCN1 PIK3CD AP5Z1 HERC6 COMT TTC28 BAZ2A CIAO3 MAP2K5 | 4.08e-05 | 198 | 234 | 10 | 4800_DN |
| Drug | Zoxazolamine [61-80-3]; Up 200; 23.8uM; MCF7; HT_HG-U133A | 4.08e-05 | 198 | 234 | 10 | 5390_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; PC3; HT_HG-U133A | 4.26e-05 | 199 | 234 | 10 | 4016_DN | |
| Drug | Yohimbinic acid monohydrate [27801-27-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | INPP1 PIDD1 SRCAP AP5Z1 KCNAB1 NLE1 PARP12 KDM5A SMG5 MAP2K5 | 4.26e-05 | 199 | 234 | 10 | 2803_DN |
| Drug | Artemisinin [63968-64-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | PIDD1 MAP3K5 AP5Z1 BAIAP3 TTC28 SPAG6 CSF1R KLF7 R3HDM1 MAP2K5 | 4.44e-05 | 200 | 234 | 10 | 7007_UP |
| Drug | benzo(a)pyrene-7,8-dione | 4.63e-05 | 20 | 234 | 4 | ctd:C076588 | |
| Drug | Chrysenes | 4.63e-05 | 20 | 234 | 4 | ctd:D002911 | |
| Drug | 20 alpha-dihydroprogesterone | 5.39e-05 | 40 | 234 | 5 | CID000008956 | |
| Drug | Flunitrazepam | 5.67e-05 | 21 | 234 | 4 | ctd:D005445 | |
| Drug | 2-cyclohexen-1-ol | 5.78e-05 | 8 | 234 | 3 | CID000013198 | |
| Drug | estrone-d4 | 6.30e-05 | 168 | 234 | 9 | CID000000698 | |
| Drug | benzene dihydrodiol | 6.88e-05 | 22 | 234 | 4 | CID000000418 | |
| Drug | Tat11 | 8.60e-05 | 9 | 234 | 3 | CID000480142 | |
| Drug | Flufenamic Acid | 9.60e-05 | 45 | 234 | 5 | ctd:D005439 | |
| Drug | Glycyrrhetinic Acid | 9.83e-05 | 24 | 234 | 4 | ctd:D006034 | |
| Drug | alpha-methylcinnamic acid | 1.05e-04 | 2 | 234 | 2 | ctd:C510582 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 1.05e-04 | 2 | 234 | 2 | DB07768 | |
| Drug | baccharin | 1.05e-04 | 2 | 234 | 2 | ctd:C012764 | |
| Drug | 9,10-phenanthrenequinone | 1.16e-04 | 25 | 234 | 4 | ctd:C005399 | |
| Drug | Pregnanolone | 1.16e-04 | 25 | 234 | 4 | ctd:D011280 | |
| Drug | sulfate | INPP1 MDM2 AP2A1 ABCC8 FBXO7 FES UGT2B17 GRIN3B KPNB1 THOC1 ABCC1 PNPLA2 FMOD COMT RELB IDS NPEPL1 SPAG5 SLC4A1 ARSD TK1 CIAO3 NAPRT INMT NCAN SIGLEC1 HAL DOT1L | 1.59e-04 | 1292 | 234 | 28 | CID000001117 |
| Drug | Fenbendazole [43210-67-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.61e-04 | 190 | 234 | 9 | 3888_UP | |
| Drug | NSC 60462 | 1.66e-04 | 11 | 234 | 3 | CID000097943 | |
| Drug | dihydrocapsaicin | 1.66e-04 | 11 | 234 | 3 | CID000107982 | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 1.81e-04 | 193 | 234 | 9 | 3973_DN | |
| Drug | felodipine; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.81e-04 | 193 | 234 | 9 | 965_DN | |
| Drug | Conessine [546-06-5]; Down 200; 11.2uM; MCF7; HT_HG-U133A | PIDD1 SRCAP USP19 PIK3CD NCKIPSD NPEPL1 CSF1R SIGLEC6 MAP2K5 | 1.88e-04 | 194 | 234 | 9 | 2792_DN |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.88e-04 | 194 | 234 | 9 | 5954_UP | |
| Drug | DO 897/99; Down 200; 8.2uM; HL60; HG-U133A | 1.88e-04 | 194 | 234 | 9 | 1728_DN | |
| Drug | Chlorogenic acid [327-97-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 3282_UP | |
| Drug | Thalidomide [50-35-1]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 5990_UP | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A | NDUFA2 MDM2 HNF4A PIK3CD BAIAP3 FKBP10 METTL25B BAZ2A SIGLEC1 | 1.96e-04 | 195 | 234 | 9 | 5256_UP |
| Drug | Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 4813_UP | |
| Drug | Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 6828_DN | |
| Drug | AC1L3VO5 | 2.00e-04 | 116 | 234 | 7 | CID000123015 | |
| Drug | Cefamandole sodium salt [30034-03-8]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 2.03e-04 | 196 | 234 | 9 | 4718_UP | |
| Drug | 6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A | 2.03e-04 | 196 | 234 | 9 | 4833_UP | |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.03e-04 | 196 | 234 | 9 | 4723_DN | |
| Drug | CAY10397; Down 200; 10uM; PC3; HT_HG-U133A | 2.03e-04 | 196 | 234 | 9 | 7087_DN | |
| Drug | Demecarium bromide [56-94-0]; Down 200; 5.6uM; PC3; HT_HG-U133A | 2.03e-04 | 196 | 234 | 9 | 5795_DN | |
| Drug | Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; PC3; HT_HG-U133A | 2.11e-04 | 197 | 234 | 9 | 7401_UP | |
| Disease | Neoplasms, Hormone-Dependent | 4.61e-07 | 3 | 229 | 3 | C0027661 | |
| Disease | Malignant neoplasm of breast | TRIML1 RPS6KB2 NDUFA2 MDM2 GALNT16 GGA3 ZCCHC14 NLE1 ASTN2 DLEC1 THEMIS2 KPNA5 ABCC1 COMT NRCAM PPM1D NUP98 CUBN HELQ TESK1 SPAG6 PBRM1 CSF1R N4BP2 | 3.74e-06 | 1074 | 229 | 24 | C0006142 |
| Disease | Hermaphroditism | 4.56e-06 | 5 | 229 | 3 | C0019269 | |
| Disease | Ambiguous Genitalia | 4.56e-06 | 5 | 229 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 4.56e-06 | 5 | 229 | 3 | C0033804 | |
| Disease | Intersex Conditions | 4.56e-06 | 5 | 229 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 4.56e-06 | 5 | 229 | 3 | C2930619 | |
| Disease | Disorders of Sex Development | 1.58e-05 | 7 | 229 | 3 | C0036875 | |
| Disease | MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE | 6.00e-05 | 2 | 229 | 2 | C1839840 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 6.00e-05 | 2 | 229 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency | 6.00e-05 | 2 | 229 | 2 | cv:C1839840 | |
| Disease | 46,XY sex reversal 8 (is_implicated_in) | 6.00e-05 | 2 | 229 | 2 | DOID:0111773 (is_implicated_in) | |
| Disease | 46,XY SEX REVERSAL 8 | 6.00e-05 | 2 | 229 | 2 | 614279 | |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 1.79e-04 | 3 | 229 | 2 | DOID:0080463 (implicated_via_orthology) | |
| Disease | platelet component distribution width | ARMC3 LRRK2 PSMD2 DLC1 CRLF3 DLEC1 BRAT1 THEMIS2 SUPT20H CFAP73 HEATR4 CUBN KLF7 BAZ2A SIGLEC1 EPAS1 | 2.97e-04 | 755 | 229 | 16 | EFO_0007984 |
| Disease | obsolete_red blood cell distribution width | LRRC24 BIRC6 VSTM4 RBM27 FBXO7 GRIN3B SPSB2 KPNB1 THEMIS2 ABCC1 TTC28 HECTD4 RELB SMG5 SLC4A1 EEF1A1 EEF1A1P5 LIMK2 METTL25B PBRM1 LRRC25 TK1 R3HDM1 | 3.55e-04 | 1347 | 229 | 23 | EFO_0005192 |
| Disease | Endometrial Stromal Sarcoma | 5.91e-04 | 5 | 229 | 2 | C0206630 | |
| Disease | age at menopause | 6.27e-04 | 302 | 229 | 9 | EFO_0004704 | |
| Disease | gamma-glutamylglutamine measurement | 6.37e-04 | 22 | 229 | 3 | EFO_0021138 | |
| Disease | sensory peripheral neuropathy, remission | 7.28e-04 | 23 | 229 | 3 | EFO_0009785, MONDO_0002321 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 8.61e-04 | 195 | 229 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | Clear cell sarcoma of kidney | 8.81e-04 | 6 | 229 | 2 | C0334488 | |
| Disease | cortolone glucuronide (1) measurement | 8.81e-04 | 6 | 229 | 2 | EFO_0800552 | |
| Disease | Idiopathic generalized epilepsy | 8.81e-04 | 6 | 229 | 2 | C0270850 | |
| Disease | Epilepsy, Generalized | 8.81e-04 | 6 | 229 | 2 | C0014548 | |
| Disease | Idiopathic generalized epilepsy | 8.81e-04 | 6 | 229 | 2 | cv:C0270850 | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 1.05e-03 | 26 | 229 | 3 | OBA_2045191 | |
| Disease | Endometrial Neoplasms | 1.08e-03 | 58 | 229 | 4 | C0014170 | |
| Disease | heparin cofactor 2 measurement | 1.23e-03 | 7 | 229 | 2 | EFO_0008150 | |
| Disease | prostate-specific antigen measurement, disease progression measurement | 1.23e-03 | 7 | 229 | 2 | EFO_0008336, EFO_0020660 | |
| Disease | hereditary spastic paraplegia (is_implicated_in) | 1.23e-03 | 7 | 229 | 2 | DOID:2476 (is_implicated_in) | |
| Disease | MASA syndrome (implicated_via_orthology) | 1.23e-03 | 7 | 229 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | non-high density lipoprotein cholesterol measurement | HNF4A DLC1 XRN1 UGT2B17 ASCC3 KPNB1 PLXNA3 COMT NRDC HEATR5A PRKAG3 PBRM1 CSF1R NCAN | 1.46e-03 | 713 | 229 | 14 | EFO_0005689 |
| Disease | Familial hyperinsulinism | 1.63e-03 | 8 | 229 | 2 | cv:C3888018 | |
| Disease | age at onset, coronary stenosis | 2.08e-03 | 9 | 229 | 2 | EFO_0004847, MONDO_0006715 | |
| Disease | Endometrial Carcinoma | 2.41e-03 | 72 | 229 | 4 | C0476089 | |
| Disease | lymphocyte count | IL16 AKR1C4 VSTM4 PIK3CD CRLF3 MCM3AP ALDH18A1 CORO7 PARP12 KPNA3 THEMIS2 ABCC1 TTC28 PCDHGA6 HECTD4 ARHGEF18 SLC4A1 PRKAG3 MST1R PBRM1 SIGLEC1 RNF39 | 2.44e-03 | 1464 | 229 | 22 | EFO_0004587 |
| Disease | low density lipoprotein cholesterol measurement, C-reactive protein measurement | 2.51e-03 | 35 | 229 | 3 | EFO_0004458, EFO_0004611 | |
| Disease | Amphetamine-Related Disorders | 2.79e-03 | 75 | 229 | 4 | C0236733 | |
| Disease | Amphetamine Abuse | 2.79e-03 | 75 | 229 | 4 | C0236807 | |
| Disease | Amphetamine Addiction | 2.79e-03 | 75 | 229 | 4 | C0236804 | |
| Disease | pulse pressure measurement | NCKAP1 POGZ SRCAP SSPOP TRIM66 DLC1 RPTOR FES DLEC1 CORO7 TTC28 KDM5A RNF213 ABCC9 NBEA HEATR5A MEI1 PBRM1 MALRD1 CPXM1 DOT1L | 2.91e-03 | 1392 | 229 | 21 | EFO_0005763 |
| Disease | X-11315 measurement | 3.15e-03 | 11 | 229 | 2 | EFO_0021223 | |
| Disease | T-cell acute lymphoblastic leukemia (is_implicated_in) | 3.15e-03 | 11 | 229 | 2 | DOID:5603 (is_implicated_in) | |
| Disease | forced expiratory volume, body mass index | 3.15e-03 | 11 | 229 | 2 | EFO_0004314, EFO_0004340 | |
| Disease | neutropenia, response to gemcitabine | 3.15e-03 | 11 | 229 | 2 | GO_0036272, MONDO_0001475 | |
| Disease | hepatocyte growth factor-like protein measurement | 3.19e-03 | 38 | 229 | 3 | EFO_0008154 | |
| Disease | nitric oxide exhalation measurement | 3.19e-03 | 38 | 229 | 3 | EFO_0005536 | |
| Disease | platelet crit | DPF1 BHLHE41 INPP1 LRRK2 VSTM4 RBM27 DQX1 THEMIS2 TTC28 HEATR4 CUBN EEF1A1P5 TGM3 FBXL16 NCAN DOT1L | 3.28e-03 | 952 | 229 | 16 | EFO_0007985 |
| Disease | Sarcomatoid Renal Cell Carcinoma | 3.29e-03 | 128 | 229 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 3.29e-03 | 128 | 229 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 3.29e-03 | 128 | 229 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 3.29e-03 | 128 | 229 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 3.29e-03 | 128 | 229 | 5 | C0007134 | |
| Disease | hyperinsulinism (is_implicated_in) | 3.76e-03 | 12 | 229 | 2 | DOID:2018 (is_implicated_in) | |
| Disease | N-acetylputrescine measurement | 3.76e-03 | 12 | 229 | 2 | EFO_0800127 | |
| Disease | Combined immunodeficiency | 3.96e-03 | 41 | 229 | 3 | C0494261 | |
| Disease | male infertility (implicated_via_orthology) | 4.42e-03 | 13 | 229 | 2 | DOID:12336 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 4.44e-03 | 261 | 229 | 7 | C0004352 | |
| Disease | dilated cardiomyopathy (is_implicated_in) | 4.53e-03 | 43 | 229 | 3 | DOID:12930 (is_implicated_in) | |
| Disease | gestational age | 4.53e-03 | 138 | 229 | 5 | EFO_0005112 | |
| Disease | Neoplastic Cell Transformation | 4.67e-03 | 139 | 229 | 5 | C0007621 | |
| Disease | body weights and measures, parental genotype effect measurement | 5.13e-03 | 14 | 229 | 2 | EFO_0004324, EFO_0005939 | |
| Disease | Maturity onset diabetes mellitus in young | 5.13e-03 | 14 | 229 | 2 | C0342276 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 5.13e-03 | 14 | 229 | 2 | EFO_0800283 | |
| Disease | lipid measurement, lipoprotein measurement | 5.36e-03 | 90 | 229 | 4 | EFO_0004529, EFO_0004732 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 5.58e-03 | 145 | 229 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 5.89e-03 | 15 | 229 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | Neurodevelopmental Disorders | 6.02e-03 | 93 | 229 | 4 | C1535926 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 6.07e-03 | 148 | 229 | 5 | C0279702 | |
| Disease | level of Sterol ester (27:1/18:1) in blood serum | 6.70e-03 | 16 | 229 | 2 | OBA_2045195 | |
| Disease | response to methotrexate | 6.70e-03 | 16 | 229 | 2 | GO_0031427 | |
| Disease | Monogenic diabetes | 6.70e-03 | 16 | 229 | 2 | C3888631 | |
| Disease | age at menarche | FAM120B AKR1C4 TRIM66 RPTOR ASCC3 UNC79 TTC28 HELQ NT5DC2 MAP2K5 EPAS1 | 7.03e-03 | 594 | 229 | 11 | EFO_0004703 |
| Disease | unipolar depression, bipolar disorder | 7.55e-03 | 156 | 229 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | Influenza | 7.71e-03 | 52 | 229 | 3 | C0021400 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VLGCFSPAEQELLPL | 176 | Q86Y79 | |
| VHCLLPPLESLATVE | 86 | P30153 | |
| LLLCSAPSAAPEALV | 201 | Q9NXW9 | |
| LCQEVEVAIPLPARS | 226 | Q9NXW9 | |
| NSPVLLEDPVLCALA | 231 | P17516 | |
| DPSAVLPLDCLLAFV | 696 | Q8N163 | |
| QLSPICPEERLLAEN | 541 | Q99814 | |
| AQLLPALCAVLVDPR | 6 | Q6PJG6 | |
| ALCAVLVDPRQPVAD | 11 | Q6PJG6 | |
| DEEPCLPRTLASLAL | 101 | Q6ZSZ5 | |
| APAARDSLPVLLFLC | 11 | P51689 | |
| QRELSLLCPGDSPAV | 356 | Q9Y614 | |
| PLSELPIELESLECP | 206 | Q8NFR7 | |
| ILDESLLETCPIQSP | 4056 | Q9NR09 | |
| AAALAALPPLLDAVC | 91 | Q16619 | |
| GLLEERPALCLSPQA | 151 | Q9UGI9 | |
| LEGFLDCSLVLPPTD | 311 | P02730 | |
| VLPRPLLSCTQALDD | 836 | O94812 | |
| APCLERAGQKLEPLA | 201 | Q9C0J9 | |
| DEVLRLCDPSAPLAF | 121 | O14514 | |
| NSPVLLEDPVLCALA | 231 | P42330 | |
| PPCLEILTNGFAVLE | 176 | Q6ULP2 | |
| LPCGLLLDELLASPE | 366 | P0CJ87 | |
| LQEVCLRPSADPIFE | 1476 | Q9UIF9 | |
| EPLLPLQCGETDLDL | 1011 | P41180 | |
| LPEGPVLEALLCAET | 111 | Q92782 | |
| VLEPVCDDLVSGLSP | 326 | O60443 | |
| LQAFLESCPPDLRAD | 386 | O75843 | |
| LNIECLRDFLTPPLL | 826 | O95782 | |
| ILACPVSDPNDLFLE | 271 | Q96SM3 | |
| PEVDVFVLLACPLGA | 331 | Q9BQC3 | |
| DACSLQPDIDLLPFG | 786 | O60706 | |
| VDLLQATLGLPACPE | 66 | O43299 | |
| PLKELCLQEPSDLRA | 586 | Q5W041 | |
| LDLASEEPERLPCLQ | 141 | Q9NWX5 | |
| LLQLKSCVPPDDALS | 656 | Q8TEK3 | |
| EPCARLLEQALELLP | 141 | A6NFT4 | |
| DFSSEVLECLPQGLP | 346 | Q8IYB7 | |
| CEIGFIPSPLRLENI | 146 | O00305 | |
| ADGLLVIPLPVEEQC | 811 | O75129 | |
| AALVRPEASVPCLIA | 1056 | Q76LX8 | |
| VGPQLRATCPLLAEL | 281 | A0A1B0GUU1 | |
| CLALIEPITSPIENI | 466 | Q8WWK9 | |
| SDPEDCLLLTRIPKV | 166 | Q8N428 | |
| DFVLNCEILPPLLEL | 206 | O15131 | |
| LKLVRSLAVCEESPP | 76 | Q15032 | |
| LLEPICDADPSALAN | 16 | Q9P2N5 | |
| LQRLTDGVCSEPLPF | 381 | Q01201 | |
| LLSPTDDLKNCIPLD | 461 | O95980 | |
| ALIVRLPFCGPNELD | 161 | A0A0X1KG70 | |
| LLLLARPASCAPDEL | 51 | Q9HCM3 | |
| QIALLDIDICGPSIP | 86 | P53384 | |
| ISCPLLILHAEDDPV | 321 | Q8N2K0 | |
| PARLNEALLEACVEP | 301 | Q96AD5 | |
| TTDPAVILDLLPLCR | 171 | Q5JU00 | |
| ECLERNPETGLDLPQ | 336 | P49441 | |
| DELCPLIVPNLGVAV | 1231 | P52948 | |
| LVTCSIPRSLPFELE | 381 | Q9Y5G7 | |
| FLSCRPTEIPENDIL | 1241 | Q86U86 | |
| PTEIPENDILLCESR | 1246 | Q86U86 | |
| PADAPLCLRLASLIE | 361 | Q06828 | |
| LPILVKCLERDDNPS | 116 | O00505 | |
| TPCPSILELEELLRA | 16 | Q6B8I1 | |
| EILLLECFAEGLPTP | 256 | O00533 | |
| ALEETDPLLLCSPAT | 196 | Q9HCH0 | |
| DPEVVSSCPDLQLRL | 1626 | Q8N201 | |
| NVLSLECIAEGLPTP | 286 | Q92823 | |
| PAVLPLADCVLTLLA | 151 | O95050 | |
| LPACRVLEPAVSARL | 101 | Q9Y543 | |
| DPDCLPRTLDFGLNV | 546 | P53671 | |
| PIAERLGCTLPQLAV | 346 | Q14722 | |
| LPLLLRESDSLEPSC | 11 | Q8N386 | |
| PLLLLLLPCEAEAAA | 71 | O75882 | |
| LRALAPSAECPIAEE | 1276 | O60318 | |
| TLDTSLGCLVPLLDP | 256 | P57737 | |
| PAFCELPLDDQVALL | 206 | P41235 | |
| LAAVPSPLELCDDAN | 81 | Q6PIU1 | |
| EEILPGFILCDPSNL | 501 | Q8IYD1 | |
| ENEAVLLPSGELLCP | 581 | P51805 | |
| LLQCIVDEDSPVLPV | 371 | Q13163 | |
| ALIVRLPFCGPNELD | 161 | Q8NGD0 | |
| ALIVRLPFCGPNELD | 161 | Q8NGB6 | |
| QLPGDPCILEFEVSI | 126 | Q08174 | |
| SEDPLLNLVSPLGCE | 491 | Q8NDH3 | |
| ILCLLVVRFDPASPS | 261 | Q7Z412 | |
| DSLPEVPLLVDVPCL | 141 | Q8IUI8 | |
| VPLLVDVPCLSAQLD | 146 | Q8IUI8 | |
| ALRQLEECVGTIPPA | 121 | Q14999 | |
| QEALSVFLLLPECPV | 476 | Q8IVU3 | |
| TCGQEARELLPLLLP | 631 | Q14005 | |
| PASLQVPEITFCEIL | 691 | Q96LU7 | |
| CAEPPRLALQSLLDV | 236 | Q50LG9 | |
| PPEIGCLENLTSLDV | 1261 | Q5S007 | |
| TAPSEALGLPDLDLC | 66 | Q8N3J3 | |
| DEELLCLGLADPAPN | 391 | Q9NZ52 | |
| FAPNAPDVLSCLELR | 1591 | Q96RT7 | |
| LVPTARKALCDPLEE | 2006 | Q92616 | |
| RLDPLLLPVEAAICE | 76 | O75840 | |
| RDVVCALLPRSLPAD | 186 | A6NGR9 | |
| PTALCEELLLPLENP | 231 | Q96FB5 | |
| EELLLPLENPCQGRA | 236 | Q96FB5 | |
| PEPLEENCAKALTLR | 471 | O15297 | |
| AANPPLCSVLLEDAR | 726 | Q6NUT2 | |
| DAADPRVACLLNVPI | 3496 | Q9Y4D8 | |
| ALSPEVLCSLALPEG | 156 | Q6XYB7 | |
| IPVDPDACILPDAAL | 116 | Q0VG06 | |
| LPACLLRDVAQEALG | 76 | P04183 | |
| PPDRVEAACQAVLEL | 241 | Q8TE96 | |
| ASQPLIDLPLIDFCD | 641 | Q9NYZ3 | |
| LPVRLPEGEALQCLT | 1236 | P29375 | |
| LSSAAGLPCEIDPAL | 961 | Q9Y2A7 | |
| GLPCEIDPALVVALS | 966 | Q9Y2A7 | |
| ESRPDCLPQVAALAI | 481 | P54886 | |
| ACALELLPDPGVSLV | 46 | Q5TIA1 | |
| APERVVLAASPLRLC | 61 | Q9H0J9 | |
| IDDIRFENCTLPLPA | 806 | Q5VYJ5 | |
| SPGARLITIEINPDC | 131 | P21964 | |
| LLADNVICPGAPDFL | 216 | P21964 | |
| LTQLCGDEKPPLIRS | 1236 | O60494 | |
| PCLLENVGEELDPAL | 3276 | Q9P2D7 | |
| QDALLPCLLTDPVLE | 121 | P07333 | |
| DAVQLETLELPPGCV | 266 | Q96AY3 | |
| LLCVALGQLDRPPDL | 506 | Q969S8 | |
| IERLCNPSLSELPAF | 471 | P42357 | |
| ALVILSELPAVCSPE | 1726 | Q86XA9 | |
| PEDETLPINVICGIL | 101 | Q5SVS4 | |
| LNTCLQELGPLEPEE | 226 | Q9BVC3 | |
| SVLEPVLERCTPDQL | 601 | Q14241 | |
| GDLICLILQDDIPAP | 71 | Q9Y3I1 | |
| TTLLEALDCILPPTR | 226 | P68104 | |
| RLNDEGPFLILCPLS | 91 | Q86WJ1 | |
| LPEVLLPALEAALCD | 526 | Q86WZ0 | |
| EAEPLLFRAVPECQL | 96 | Q9Y2G2 | |
| PSERPALCFLLLAVA | 6 | Q9NZK5 | |
| AACVPVVNDISPRLL | 1976 | Q0VDD8 | |
| PLLQCLIEGLSAEPR | 451 | Q14974 | |
| LTDDSPVDLLCAPVP | 1616 | Q9Y4F3 | |
| TTLLEALDCILPPTR | 226 | Q5VTE0 | |
| RLLLTQPGCDPAILD | 746 | Q6NY19 | |
| ILFCADLPSLIQEGP | 116 | Q5BKX5 | |
| NLLCPVDVLDVPEGT | 181 | P22304 | |
| VEVQPLLLSDSPECL | 61 | Q8TDG4 | |
| LLEEAVPLSCALPKV | 261 | Q96DZ5 | |
| LNCVTIALERPDIDP | 1306 | O95180 | |
| DLIPEQPCSGVLSEL | 1486 | Q9Y238 | |
| QEEGLAAVCTPALRP | 921 | Q12770 | |
| RTADPAILPNILICL | 871 | Q68D06 | |
| PLIGLIPSCQLEIES | 131 | Q6ZTR5 | |
| VLRAPAALPALCDLL | 31 | Q8TEX9 | |
| ALQRSPETPLEICLV | 806 | Q5VV67 | |
| PGFENIELTPLAAIC | 241 | Q6P995 | |
| DLPLLACLLGNDIIP | 221 | Q96EK7 | |
| LLGEPEAAVSPLLCL | 506 | Q9HB75 | |
| IPALLPLACADTSLA | 181 | Q8NH80 | |
| CEELTAVLTPPQLLG | 26 | Q9H300 | |
| IQACALLPDLEILPS | 741 | P33527 | |
| LVAVKSCRETLPPDL | 586 | P07332 | |
| NFELLLGPICLPLVD | 241 | Q99683 | |
| PDTEALSCFLIPVLR | 351 | Q8IVF1 | |
| PDTEALSCFLIPVLR | 351 | A6NNL0 | |
| PDTEALSCFLIPVLR | 351 | B1AL46 | |
| PVPAAVLLGCDIARA | 231 | O60391 | |
| KANPDLPILIRECSD | 46 | O43678 | |
| VSLCPQGLVDPADLA | 116 | Q9NXI6 | |
| ELELTNCPGATPELF | 451 | Q8N461 | |
| TINLLKPLPVEDSDC | 66 | Q8TC99 | |
| LVCNALLAQEDPLPL | 46 | Q9NVX2 | |
| RSLLVINFDLEPECP | 1606 | Q2M3C7 | |
| EQLLCGRPPDLTALS | 416 | Q96R06 | |
| AGAVPLLVLCIQEPE | 166 | O75602 | |
| APLLVLCPSRAELDR | 166 | Q494U1 | |
| TLLLDECPLPTKDAL | 161 | Q96DX4 | |
| ILATAEPLCLDPSVA | 201 | Q3ZLR7 | |
| PLIAKADCLVPSEIR | 186 | Q99719 | |
| EVAPRQEDLVPCASL | 31 | A2VEC9 | |
| QDLLEGCELPDLPSS | 711 | Q9UPR3 | |
| PALALLREGCPADTS | 121 | H3BV60 | |
| PELSPADACPLAELR | 21 | Q9UBS0 | |
| PEPENSALLRCALGV | 241 | Q13200 | |
| ALALPPLATEGAECL | 926 | Q7Z3K3 | |
| ALEGPENCLFPRLIS | 2816 | Q8NFP9 | |
| LAELVALPCLFTLQP | 51 | O14594 | |
| VESSLPLNAIEPCVI | 426 | Q00987 | |
| IAQLELDPKCRGLPF | 391 | Q8N5V2 | |
| LLTLDVELPPVCSDI | 186 | Q9NZH4 | |
| SPLLCPERQEDILDS | 136 | Q6ZNE9 | |
| QEDVEPFLCILLPAT | 46 | A0A1B0GU29 | |
| SLPVLEGQALRLLCD | 261 | O43699 | |
| DPLALSELPGLFDCE | 896 | Q9H0K1 | |
| VQELARLDPSLCDPL | 546 | Q2M3G4 | |
| RTADPAILPNVLICL | 871 | Q7Z7L1 | |
| ILCDDLDLNPLTFVP | 221 | Q12824 | |
| TNLPLGLRPEAELCA | 2541 | Q6ZRS2 | |
| ELPLCVSESNGLELP | 2641 | Q6ZRS2 | |
| EFLDTPCTNRGLPLL | 256 | Q96QB1 | |
| AERLCGEASLQAVPP | 481 | Q7RTU9 | |
| PLACFLSPEELQSLV | 931 | Q7RTU9 | |
| GLPLDTTEQLPDLCV | 541 | Q9NZQ3 | |
| ALVLCLNVGVDPPDV | 61 | Q8N122 | |
| ACISLPLLPRIEEAL | 66 | Q3KNW1 | |
| ILATAEPLCLDPSVA | 201 | P0C7V6 | |
| LFSNPLDEPVRDCVL | 616 | Q08188 | |
| VIEACSLQPDIDILP | 801 | Q09428 | |
| NSPVLLEDPVLCALA | 231 | Q04828 | |
| NSPVLLEDPVLCALA | 231 | P52895 | |
| ERALALPEICTQCPG | 26 | Q6UW56 | |
| LLLLPASDDVCTAPG | 721 | Q8N957 | |
| ELLDLQPLPITALGC | 1301 | Q8N3C0 | |
| VSLPDLEPAPLDSLC | 286 | Q9H6Q4 | |
| CLLSLLPVPRDVLET | 631 | Q9ULV3 | |
| LELLDQRGCPPNFLE | 306 | Q96PV4 | |
| RDLSNINCEELGPLP | 286 | Q9HAU4 | |
| RLCLTLGIPQATDPD | 2376 | Q63HN8 | |
| PCFLLLALVLVPSDA | 16 | Q5JXA9 | |
| LLVEADEQLCIPPLN | 201 | O94966 | |
| DTDNDLVPPLELCIR | 726 | Q4G0A6 | |
| SCNDLTEILIPEALP | 721 | Q6ZVD8 | |
| FEQLCASLLARVEPP | 306 | O95757 | |
| LVTLPCLQPEVDGEA | 831 | Q9BXM0 | |
| VLQDPALKDLVLTCP | 181 | Q5TEJ8 | |
| PDLSCPEGLEELLSA | 21 | Q99619 | |
| LATAEPLCLDPSIAV | 201 | Q8NEM7 | |
| RVIFSIPCEPNLDAL | 886 | Q8IZH2 | |
| DLIPCSDLPSLDAIG | 106 | O75631 | |
| SPLLADCIIPITDIR | 1121 | O43847 | |
| DSAAALLICLPEVAP | 466 | O00329 | |
| LCDALLISQDSPPVL | 441 | Q8IYM2 | |
| PLLLILDRCDDAITP | 211 | Q9NRW7 | |
| GQLCEPLPSLAESRA | 481 | Q6XQN6 | |
| TLVGDDCPLPFLLLA | 276 | Q15569 | |
| GLLLCRVDSDPPAQL | 1001 | Q9BZZ2 | |
| NRELTDLLPPEVCSL | 36 | Q9H857 | |
| TQLCLLFPPDESIDL | 486 | Q96MU7 | |
| IAPGDERQCLPSLDL | 1491 | P78527 | |
| LERSEPLLLQCPEAT | 251 | Q8N9V2 | |
| LLSLCEAPAVPALRL | 121 | Q9ULQ1 | |
| ENLEKLIPCLAGPDA | 151 | Q8WYQ9 | |
| DGESISDCPPLQELL | 1591 | Q96AY4 | |
| SDCPPLQELLLTAAD | 1596 | Q96AY4 | |
| DILLNPVLALSFCPD | 326 | Q8N398 | |
| SAPEPRVLVCLGALL | 6 | Q8N0Z9 | |
| AERLCGEASLQAVPP | 481 | A6NGW2 | |
| PLACFLSPEELQSLV | 931 | A6NGW2 | |
| CTDLRPLDILAEVVP | 26 | Q8WU66 | |
| LLARAPAPEVCAALN | 11 | Q8IW00 | |
| LPLFQLVLSDLPCEE | 21 | Q6UWW9 | |
| EEPLNSVLFLRPISC | 556 | O60294 | |
| ARLPRDTVCLDTLPA | 136 | Q9BQ50 | |
| LCPRDGADPSLENAL | 781 | O15016 | |
| KVLVLDPALPALVSC | 121 | Q04912 | |
| VLLPLLESCSVRPDA | 461 | Q9BQ70 | |
| PCGELLAELLNIPFL | 156 | O75795 | |
| STPFVLLGDVLDCLP | 91 | Q96FV9 | |
| PGLVERLEQLATCPL | 76 | Q9H2S5 | |
| CLLPFLNDDILSTLP | 161 | Q9P2D8 | |
| LTIDCLELALPPELA | 1371 | Q86UW6 |